Why the study?
Angiotensin-converting enzyme 2 has drawn major attention as the SARS-CoV-2 receptor and a key RAS counter-regulator implicated in cardiovascular, renal, lung diseases, and diabetes.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
ACE2 plays a critical protective role in the renin-angiotensin system, with broad implications for cardiovascular, renal, and pulmonary pathophysiology beyond its role as the SARS-CoV-2 receptor.
Since the worldwide outbreak of coronavirus disease 2019, angiotensin-converting enzyme 2 (ACE2) has received widespread attention as the cell receptor of the severe acute respiratory syndrome coronavirus 2 virus. At the same time, as a key enzyme in the renin-angiotensin-system, ACE2 is considered to be an endogenous negative regulator of vasoconstriction, proliferation, fibrosis, and proinflammation caused by the ACE-angiotensin II-angiotensin type 1 receptor axis. ACE2 is now implicated as being closely connected to diabetes, cardiovascular, kidney, and lung diseases, and so on. This review covers the available information on the host factors regulating ACE2 and discusses its role in a variety of pathophysiological conditions in animal models and humans.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: